Compare LACTOSE INDIA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs MEDICO REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA MEDICO REMEDIES LACTOSE INDIA/
MEDICO REMEDIES
 
P/E (TTM) x -120.5 - - View Chart
P/BV x 1.9 4.4 42.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LACTOSE INDIA   MEDICO REMEDIES
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
MEDICO REMEDIES
Mar-21
LACTOSE INDIA/
MEDICO REMEDIES
5-Yr Chart
Click to enlarge
High Rs42105 39.8%   
Low Rs1667 23.9%   
Sales per share (Unadj.) Rs30.6294.9 10.4%  
Earnings per share (Unadj.) Rs-2.26.2 -34.7%  
Cash flow per share (Unadj.) Rs1.610.2 16.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs30.178.2 38.5%  
Shares outstanding (eoy) m11.444.15 275.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.90.3 324.0%   
Avg P/E ratio x-13.313.8 -96.8%  
P/CF ratio (eoy) x17.68.4 208.8%  
Price / Book Value ratio x1.01.1 87.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m330357 92.5%   
No. of employees `000NANA-   
Total wages/salary Rs m10645 236.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3501,224 28.6%  
Other income Rs m310 30.4%   
Total revenues Rs m3531,234 28.6%   
Gross profit Rs m6252 119.0%  
Depreciation Rs m4417 263.8%   
Interest Rs m549 590.9%   
Profit before tax Rs m-3337 -88.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-811 -72.5%   
Profit after tax Rs m-2526 -95.6%  
Gross profit margin %17.84.3 416.6%  
Effective tax rate %24.229.7 81.7%   
Net profit margin %-7.12.1 -334.6%  
BALANCE SHEET DATA
Current assets Rs m197594 33.2%   
Current liabilities Rs m116388 30.0%   
Net working cap to sales %23.116.8 137.4%  
Current ratio x1.71.5 110.7%  
Inventory Days Days598 700.8%  
Debtors Days Days67181,793,146 0.0%  
Net fixed assets Rs m686171 401.8%   
Share capital Rs m11441 275.7%   
"Free" reserves Rs m230283 81.4%   
Net worth Rs m345325 106.2%   
Long term debt Rs m39350 793.2%   
Total assets Rs m883765 115.5%  
Interest coverage x0.45.0 8.0%   
Debt to equity ratio x1.10.2 746.6%  
Sales to assets ratio x0.41.6 24.7%   
Return on assets %3.44.6 73.2%  
Return on equity %-7.28.0 -90.0%  
Return on capital %3.012.3 24.0%  
Exports to sales %083.2 0.0%   
Imports to sales %7.46.4 116.2%   
Exports (fob) Rs mNA1,018 0.0%   
Imports (cif) Rs m2678 33.2%   
Fx inflow Rs m251,018 2.4%   
Fx outflow Rs m2779 33.8%   
Net fx Rs m-2939 -0.2%   
CASH FLOW
From Operations Rs m2226 83.0%  
From Investments Rs m-62-1 8,234.7%  
From Financial Activity Rs m45-4 -1,288.9%  
Net Cashflow Rs m522 23.5%  

Share Holding

Indian Promoters % 52.5 73.3 71.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 47.5 26.7 178.2%  
Shareholders   15,696 120 13,080.0%  
Pledged promoter(s) holding % 41.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Pares Losses to Trade Flat, Nifty Near 17,150; Axis Bank Jumps 5% Post Stellar Q3 Results(10:30 am)

Asian stock markets are trading sharply lower today with investors remaining cautious over geopolitical risks linked to Ukraine and the US Federal Reserve's decision later this week.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Jan 25, 2022 11:43 AM

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA - PANACEA BIOTECH COMPARISON

COMPARE LACTOSE INDIA WITH

MARKET STATS